Blar i HV - Institutt for naturvitenskapelige helsefag på emneord "Biomarkers"

Viser treff 1-5 av 5

    • Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic 

      Müller, Ebba Gløersen; Edwin, Trine Holt; Stokke, Caroline; Navelsaker, Sigrid Stensby; Babovic, Almira; Bogdanovic, Nenad; Knapskog, Anne Brita; Revheim, Mona-Elisabeth (PLoS ONE;14(8): e0221365, Journal article; Peer reviewed, 2019-08-05)
      Background: Alzheimer’s disease (AD) remains a clinical diagnosis but biomarkers from cerebrospinal fluid (CSF) and more lately amyloid imaging with positron emission tomography (PET), are important to support a diagnosis ...

    • Diagnostic accuracy and added value of infection biomarkers in patients with possible sepsis in the emergency department 

      Christensen, Erik Egeland; Binde, Christina; Leegaard, Marianne; Tonby, Kristian; Dyrhol-Riise, Anne Ma; Kvale, Dag; Amundsen, Erik Koldberg; Holten, Aleksander Rygh (Shock;Vol. 58, No. 4, Peer reviewed; Journal article, 2022)
      Background: Biomarkers for early recognition of infection are warranted. The hypothesis of this study was that calprotectin, C-reactive protein (CRP), IL-6 and procalcitonin (PCT), alone or in combination, provide clinically ...

    • Dietary Immunostimulant CpG Modulates MicroRNA Biomarkers Associated with Immune Responses in Atlantic Salmon (Salmo salar) 

      Xue, Xi; Woldemariam, Nardos Tesfaye; Rise, Matthew L.; Andreassen, Rune (Cells;Volume 8, Issue 12, Journal article; Peer reviewed, 2019-12-05)
      MicroRNAs (miRNAs) are key regulators in fish immune responses. However, no study has previously characterized the impact of polyriboinosinic polyribocytidylic acid (pIC) and formalin-killed typical Aeromonas salmonicida ...

    • LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer 

      Sas-Chen, Aldema; Aure, Miriam Ragle; Leibovich, Limor; Carvalho, Silvia; Enuka, Yehoshua; Körner, Cindy; Polycarpou-Schwarz, Maria; Lavi, Sara; Nevo, Nava; Kuznetsov, Yuri; Yuan, Justin; Azuaje, Francisco; Ulitsky, Igor; Diederichs, Sven; Wiemann, Stefan; Yakhini, Zohar; Kristensen, Vessela N.; Børresen-Dale, Anne-Lise; Yarden, Yosef; Sauer, Torill; Geisler, Jürgen; Hofvind, Solveig; Bathen, Tone Frost; Borgen, Elin; Engebråten, Olav; Fodstad, Øystein; Garred, Øystein; Geitvik, Gry; Kåresen, Rolf; Naume, Bjørn; Mælandsmo, Gunhild; Russnes, Hege Elisabeth Giercksky; Schlichting, Ellen; Sørlie, Therese; Lingjærde, Ole Christian; Sahlberg, Kristine Kleivi; Skjerven, Helle; Fritzman, Britt (Journal article; Peer reviewed, 2016)
      Long noncoding RNAs (lncRNAs) are emerging as regulators of gene expression in pathogenesis, including cancer. Recently, lncRNAs have been implicated in progression of specific subtypes of breast cancer. One aggressive, ...

    • Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission 

      Kvist, Beate Charlotte Fagerlund; Chudasama, Kishan Kumar; Brurberg, Kjetil Gundro; Robberstad, Bjarne; Rose, Christopher James; Juvet, Lene Kristine; Fretheim, Atle (Book; Peer reviewed; Research report, 2019-08-16)
      Breast cancer can be treated with chemotherapy, hormone therapy and radiation, or a combination of these to prevent the spread of cancer cells, after surgical removal of the tumor. When assessing whether a patient should ...